BioMarin Pharmaceutical Inc. (BMRN)

Last Closing Price: 61.42 (2026-11-19)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioMarin Pharmaceutical Inc. (BMRN) had Revenue of $1.02B for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
Revenue
$1.02B
$-122.83M
$205.42M
$819.23M
$1.11B
$-82.08M
$-49.69M
$-131.77M
$-131.77M
$-122.83M
$-122.83M
$-122.83M
$-122.83M
$-82.08M
$48.38M
193.59M
193.59M
$-0.63
$-0.63
Balance Sheet Financials
$3.92B
$980.08M
$7.65B
$11.57B
$1.60B
$3.51B
$3.71B
$5.31B
$6.26B
$812.42M
$6.26B
193.68M
Cash Flow Statement Financials
$576.97M
$-4.68B
$3.53B
$1.31B
$736.01M
$-575.67M
$172.68M
--
--
Fundamental Metrics & Ratios
2.44
--
--
0.36
0.67
79.95%
-8.01%
-8.01%
--
-12.86%
-11.99%
$498.94M
--
--
--
0.09
0.11
0.95
94.54
-1.96%
-15.12%
-1.06%
-1.26%
$32.30
$2.58
$2.98